COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes

Figure 1

Analysis of immune cells and cytokines in the four subgroups of patients with COVID-19 or cancer. : nonsevere; : severe. (a) IL-2 (left), IL-10 (middle), and CD3⁺ Abs (right). (b) CD3⁺CD4⁺ Abs (left), CD3⁺CD8⁺ Abs (middle), and CD19⁺ Abs (right). (c) CD16⁺CD56⁺ Abs (left), LYM (middle), and NEU (right).

(a)

(b)

(c)